TXG
NASD 10x Genomics Inc Class A$90.36 ↑ +0.00 (+0.00%) Trading Up from the previous close of $90.36, $4.80 below the day’s high of $95.16
- YTD change
- +454.02%
- vs 20-day SMA
- +22.95%
- vs 200-day SMA
- +168.74%
Price ranges
Price & Performance
+70.55 (+356.13%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 56.8% away from all-time highs of $208.99
- TXG is up 454% since the beginning of the year
- TXG is up 673% over the past 12 months
- TXG is up 45% over the past 1 month
- 14% of all TXG investors are betting against TXG
TXG reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +673.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.30
- Last 5 days
- +11.97%
- vs 8-day SMA
- +9.46%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.